Accelerate from advanced therapy (AT) developer to established AT manufacturer with the Cell and Gene Therapy Catapult

Learn more about how the Cell and Gene Therapy Catapult can support your organisation at our Boston Showcase event.

Are you looking to make your ATMP processes more cost-efficient, safe and robust as you prepare to up-scale? Or perhaps your organisation is ready to develop their own manufacturing capabilities?

Key players in the advanced therapies space are invited to attend this in-person breakfast event at the MassBio Hub in Boston (18th September, 7:30am-9.30am), to learn how the Cell and Gene Therapy Catapult can provide support for US-based advanced therapy developers looking to de-risk and rapidly establish robust in-house manufacturing capability.

At this event, we will share insights and lessons learned from our 10+ years of experience in supporting multiple advanced therapy companies to licensure, with accelerated timelines and minimal resources.

We encourage cell and gene therapy developers looking to establish GMP manufacturing operations at a clinical and commercial scale to attend, as an opportunity to access manufacturing innovation expertise, world-class facilities and the largest cell and gene therapy cluster with established supply chain outside the US.

If you would like to attend, to learn how we can work together to increase the value of your asset(s) and expedite your access to European and global markets, please contact John Kelly at the Cell and Gene Therapy Catapult: